Research shows low percentage of US sickle cell patients receive red blood cell exchange treatment
The Guardian · September 27, 2026Original source ↗
What happened
A study found that only 3% of sickle cell patients in the US receive red blood cell exchange therapy. This procedure, which can replace damaged red blood cells with healthy ones, is available in many hospitals across the country.
Why it matters
Understanding the treatment disparity highlights potential barriers to effective healthcare for sickle cell patients.
How this story affects people
How does this story affect you if you are a sickle cell patient?
This study highlights that you may be missing out on an effective treatment that could significantly improve your health. With only 3% of patients receiving red blood cell exchange therapy, you might face barriers that prevent you from accessing this potentially life-changing procedure.
How does this story affect you if you are a healthcare provider?
This research indicates that many of your sickle cell patients are not receiving a widely available treatment. Understanding the reasons behind this disparity could help you advocate for better access and care for these patients.
Want this written about you?
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Get your Ripple